SPORTS
SUPPLEMENT ACQUISITION GROUP, INC.

    VOTING
AGREEMENT

    


    


    THIS
VOTING AGREEMENT (this “Agreement”) is entered into as of the 10th day of
December, 2008, by and among Sports Supplement Acquisition Group, Inc., a
Delaware corporation (the “Company”), and Proviant Technologies, Inc., an
Illinois corporation (“Proviant”) and The James Klein Family Trust (“Klein” and,
together with Proviant, the “Shareholders”).

    


    RECITALS:

    


    A.  Klein owns a majority of
the issued and outstanding shares of Common Stock, par value $0.001 per share
(the “Common Stock”), of the Company on the date hereof.

    


    B.  Pursuant to that Asset
Purchase, Technology Transfer and License Agreement by and between the Company
and Proviant, dated of even date herewith (the “Purchase Agreement”), Proviant
agreed to transfer or license to the Company certain assets in return for the
consideration set forth in the Purchase Agreement, which consideration included
400 shares of the Company’s Common Stock, on the terms and conditions set forth
in the Purchase Agreement.  Capitalized terms used herein but not
otherwise defined shall have the respective meanings ascribed to them in the
Purchase Agreement.

    


    C.  In order to induce
Proviant to enter into the Purchase Agreement, Klein has agreed to enter into
this Voting Agreement to provide certain voting agreements with respect to the
election of the directors to the Company’s Board of Directors.

    


    NOW, THEREFORE, in consideration of the
mutual promises and other consideration hereinafter set forth, the receipt and
sufficiency of which are hereby acknowledged by the parties hereto, the parties
agree as follows:

    


    1.           VOTING.

    


    Pursuant to the By-laws of the Company,
the number of directors to comprise the Company’s Board of Directors (the
“Company Board”) has been fixed at five.  Each Shareholder hereby
agrees that from and after the date hereof, such Shareholder will vote all
shares of the Company’s capital stock over which such Shareholder has voting
control or are owned by such Shareholder, beneficially or of record, on the
record date fixed for a determination of those shareholders entitled to vote in
any election of directors of the Company, or will cause such shares to be voted
and shall take all other necessary or desirable actions within such
Shareholder’s control (including in his or her capacity as a shareholder,
director, member of a board committee or officer of the Company or otherwise,
and including, without limitation, attendance at meetings in person or by proxy
for purposes of obtaining a quorum and execution of written consents in lieu of
meetings), and the Company shall take all necessary or desirable actions within
its control (including, without limitation, calling special board and
shareholder meetings), so that:

    


    
      
         

      

      
         

        
          

        

      

      
         

      

       

    

    (i)           the
authorized number of directors on the Company Board is established and remains
at five directors, except as otherwise set forth herein or, until such time as
the Notes are paid in full, with the written consent of Proviant, not to be
unreasonably withheld;

    


    (ii)                      there
shall be elected to the Company Board (A) Klein and two persons nominated by
Klein, (B) one person nominated by Proviant (the “Proviant Director”), and (C)
one person nominated by Cynergi Holdings;

    


    (iii)                      any
committees of the Company Board shall be created only upon the approval of a
majority of the Company Board and the membership of each such committee (if any)
shall include the Proviant Director;

    


    (iv)                      the
membership of the board of directors or other governing body of any subsidiary
of the Company shall include the Proviant Director;

    


    (v)           there
shall not be removed from the Company Board, with or without cause, any Proviant
Director without the written request of Proviant;

    


    (vi)                      in
the event that Proviant requests in writing that any Proviant Director be
removed from the Company Board or any committee thereof, such director shall be
so removed;

    


    (vii)                      in
the event that any Proviant Director ceases to serve as a member of the Company
Board during his or her term of office, the resulting vacancy on the Company
Board shall be filled by a representative who shall be a new Proviant Director
designated in the same manner as such former Proviant Director; and

    


    (viii)                      each
member of the Company Board or any committee thereof shall be reimbursed for
reasonable out-of-pocket expenses incurred as a result of fulfilling his or her
duties as a Director of the Company.

     

    2.           APPOINTMENT
OF ADDITIONAL PROVIANT DIRECTORS.

     

    Upon an event of default under any of
the Notes, Proviant may appoint such additional members to the Company Board
pursuant to Section 1 as provided in any such Note and the Shareholders and the
Company shall take and vote in favor of any and all actions necessary to permit
such appointment(s), including, but not limited to, increasing the authorized
number of directors on the Company Board accordingly.

    


    
      
         

      

      
        -2-

        
          

        

      

      
         

      

       

    

    3.           MISCELLANEOUS.

    


    3.1                      Consent
Required.  Any term, covenant, agreement or condition of this
Agreement may be amended or compliance therewith may be waived (either generally
or in a particular instance and either retroactively or prospectively), with the
consent of each of the parties hereto.

    


    3.2                      Notices.  All
communications (other than those sent to shareholders generally) provided for
hereunder shall be in writing and delivered or mailed by registered or certified
mail, by reputable overnight delivery, or by telecopy to the Shareholder’s
address in the Company’s stock record books.

    


    3.3                      Successors and
Assigns.  This Agreement shall inure to the benefit of and be
binding upon the Company and its successors and assigns and shall inure to the
benefit of and be binding upon each Shareholder and each Shareholder’s
successors and assigns.

    


    3.4                      Governing
Law.  This Agreement and securities issued and sold hereunder
shall be governed by and construed in accordance with Illinois law, without
reference to conflict of laws principles.

    


    3.5                      Captions.  The
descriptive headings of the various Sections or parts of this Agreement are for
convenience only and shall not affect the meaning or construction of any of the
provisions hereof.

    


    3.6                      Number and
Gender.  Where required by the context, singular words or
pronouns shall be construed as plural, plural words and pronouns shall be
construed as singular and the gender of personal pronouns shall be construed as
either masculine, feminine or neuter.

    


    3.7                      Severability.  In
the event that any one or more of the provisions contained in this Agreement or
in any instrument referred to herein shall, for any reason, be held to be
invalid, illegal or unenforceable, such invalidity, illegality or
unenforceability shall not affect any other provisions of this
Agreement.

    


    3.8                      Entire
Agreement.  This Agreement contains the entire agreement of the
parties with respect to the subject matter hereof, and supersedes all prior
and/or contemporaneous agreements.

    


    3.9                      Counterparts.  This
Agreement may be executed in any number of counterparts, each of which shall be
deemed an original, but all of which taken together shall constitute one and the
same instrument.

    


    3.10                      Termination.  This
Agreement shall terminate upon the earlier of (i) the Company’s sale, lease or
other disposition of all or substantially all of its assets, (ii) the
acquisition of the Company by another entity by means of merger or consolidation
resulting in the exchange of the outstanding shares of the Company for
securities or consideration issued, or caused to be issued, by the acquiring
Company or its subsidiary (other than a merger effected exclusively for the
purpose of changing the domicile of the Company), or (iii) a transaction or
series of related transactions in which the stockholders of the Company owning a
majority of the voting power of the Company immediately prior to such
transaction do not own a majority of the outstanding shares of the capital stock
or equity interests of the entity surviving the transaction; provided Proviant
is a party thereto.

    


    
      
         

      

      
        -3-

        
          

        

      

      
         

      

       

    

    3.11                      Injunctive
Relief.  In addition to its right to damages and any other
right it may have, each party hereto shall have the right to obtain injunctive
or other equitable relief to restrain any breach or threatened breach of or
otherwise to specifically enforce this Agreement, it being agreed that money
damages alone would be inadequate to compensate such party and would be an
inadequate remedy for such breach.

    


    3.12                      Counsel
Fees.  If any action at law or in equity is necessary to
enforce or interpret the terms of this Agreement, the prevailing party shall be
entitled to reasonable attorneys’ fees, costs and necessary disbursements in
addition to any other relief to which each party may be entitled.

    


    IN WITNESS WHEREOF, the parties have
executed this Agreement as of the date first written above.

    


    
      
        	
                Proviant
      Technologies, Inc.

              	
                Sports
      Supplement Acquisition Group, Inc.

              
	 
      	 
      
	 
      	 
      
	
                By
      /s/ Ramlakhan
      Boodram                        
      

              	
                By
      /s/ James
      Klein                                            
      

              
	
                Name:
      Ramlakhan Boodram

              	
                Name:
      James Klein

              
	
                Title:
      President

              	
                Title:
      President

              


      

    

    


    


    The James
Klein Family Trust

    


    


     /s/ James
Klein                                           


    Per: James
Klein, Trustee

     

    
      
         

      

      
        -4-